0000899243-19-013799.txt : 20190516 0000899243-19-013799.hdr.sgml : 20190516 20190516173855 ACCESSION NUMBER: 0000899243-19-013799 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190514 FILED AS OF DATE: 20190516 DATE AS OF CHANGE: 20190516 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hawkins Richard J CENTRAL INDEX KEY: 0001307632 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32157 FILM NUMBER: 19833516 MAIL ADDRESS: STREET 1: 950 TOWER LANE, SUITE 900 CITY: FOSTER CITY STATE: CA ZIP: 94404-2125 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Savara Inc CENTRAL INDEX KEY: 0001160308 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841318182 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 900 S. CAPITAL OF TEXAS HIGHWAY STREET 2: SUITE 150 CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: 512-614-1848 MAIL ADDRESS: STREET 1: 900 S. CAPITAL OF TEXAS HIGHWAY STREET 2: SUITE 150 CITY: AUSTIN STATE: TX ZIP: 78746 FORMER COMPANY: FORMER CONFORMED NAME: Mast Therapeutics, Inc. DATE OF NAME CHANGE: 20130312 FORMER COMPANY: FORMER CONFORMED NAME: ADVENTRX PHARMACEUTICALS INC DATE OF NAME CHANGE: 20030613 FORMER COMPANY: FORMER CONFORMED NAME: BIOKEYS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20010928 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-05-14 0 0001160308 Savara Inc SVRA 0001307632 Hawkins Richard J 6836 BEE CAVE ROAD, BUILDING III SUITE 200 AUSTIN TX 78746 1 0 0 0 Common Stock 2019-05-14 4 M 0 21682 0.52 A 21682 D Common Stock 2019-05-14 4 M 0 586 0.52 A 22268 D Common Stock 2019-05-14 4 M 0 2288 0.52 A 24556 D Common Stock 2019-05-14 4 M 0 444 0.55 A 25000 D Common Stock 2019-05-14 4 S 0 14591 11.0654 D 10409 D Common Stock 2019-05-15 4 S 0 10409 11.1602 D 0 D Stock Option (Right to Buy) 0.52 2019-05-14 4 M 0 21682 0.00 D 2020-10-22 Common Stock 21682 0 D Stock Option (Right to Buy) 0.52 2019-05-14 4 M 0 586 0.00 D 2020-12-17 Common Stock 586 0 D Stock Option (Right to Buy) 0.52 2019-05-14 4 M 0 2288 0.00 D 2021-08-30 Common Stock 2288 0 D Stock Option (Right to Buy) 0.55 2019-05-14 4 M 0 444 0.00 D 2021-12-16 Common Stock 444 728 D The price is a weighted average sale price. The sale prices ranged from $10.97 to $11.16. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The price is a weighted average sale price. The sale prices ranged from $10.99 to $11.31. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. 5,420 of the shares subject to the option vested and became exercisable on October 22, 2010, and the remaining shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on January 22, 2011. The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on March 17, 2011. The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on November 18, 2011. The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on March 16, 2012. /s/ David Lowrance as attorney-in-fact for Richard J. Hawkins 2019-05-16